Acquired C1 esterase inhibitor deficiency

Annals of Internal Medicine

Volumn 132, Issue 2, 2000, Pages 144-150

  Markovic, Svetomir N ^a   Inwards, David J ^a   Frigas, Evangelos A ^a   Phyliky, Robert P ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4;

ADULT; AGED; ANGIONEUROTIC EDEMA; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; ENZYME BLOOD LEVEL; ENZYME DEFICIENCY; FEMALE; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL; REVIEW;

EID: 0033974103     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-132-2-200001180-00009     Document Type: Review

References (32)

1. Oltvai ZN, Wong EC, Atkinson JP, Tung KS. C1 inhibitor deficiency: molecular and immunologic basis of hereditary and acquired angioedema Lab Invest. 1991;65:381-8.
2. Davis AE. Hereditary and acquired deficiencies of C1 inhibitor. Immunodeficiency Rev. 1989;1:207-26.
3. Quincke H. Über akutes umschriebenes H-autodem. Monatshefte für Praktische Dermatologie. 1882;1:129-31.
4. Osler W. Hereditary angioneurotic oedema. Am J Med Sci. 1888;95:362-7.
5. Frigas E. Angioedema with acquired deficiency of the C1 inhibitor: a constellation of syndromes. Mayo Clin Proc. 1989;64:1269-75.
6. Alsenz J, Loos M. The acquired C1-INH deficiencies with autoantibodies (AAE type II) Behring Inst Mitt. 1989;84:165-72.
7. Gerencer M, Burek V, Barrett NP, Dorner F. Acquired deficiency of functional C1-esterase inhibitor in HIV type 1-infected patients. AIDS Res Hum Retroviruses. 1997;13:813-4.
8. Gordon EH, Beall GN, Klaustermeyer WB. Angioedema and multiple myeloma. I. Ann Allergy. 1983;51:349-50.
9. Demer A, Garban F, LeTourneau A, Conard J, Weiss L, Diebold J, et al. Waldenstrom's macroglobulinemia with prominent splenomegaly and multiple immune disorders. Hematologica. 1993;78:408-10.
10. Casali P, Bozzini P, Pioltelli P, Invernizzi F, Zanussi C. Acquired C1-inhibitor deficiency in essential cryoglobulinemia and macroglobulinemia. Acta Haematol. 1978;59:277-84
11. Wasserfallen JB, Spaeth P, Guillou L, Pecoud AR. Acquired deficiency in C1-inhibitor associated with signet ring cell gastric adenocarcinoma: a probable connection of antitumor-associated antibodies, hemolytic anemia, and complement turnover. J Alergy Clin Immunol. 1995;95:124-31.
12. Caldwell JR, Ruddy S, Schur PH, Austen KF. Acquired C1 inhibitor deficiency in lymphosarcoma. Clin Immunol Immunopathol. 1972;1:39-52.
13. Mathur R, Toghill PJ, Johnston ID. Acquired C1 inhibitor deficiency with lymphoma causing recurrent angioedema. Postgrad Med. 1993;69:646-8.
14. Cohen SH, Koethe SM, Kozin F, Rodey G, Arkins JA, Fink JN. Acquired angioedema associated with rectal carcinoma and its response to danazol therapy. Acquired angioedema treated with danazol. J Allergy Clin Immunol. 1978;62:217-21.
15. Cicardi M, Bisiani G, Cugno M, Spaeth P, Agostoni A. Autoimmune C1 inhibitor deficiency: report of eight patients. Am J Med. 1993;95:169-75.
16. Day NK, Winfield JB, Gee T, Winchester R, Teshima H, Kunkel HG. Evidence for immune complexes involving anti-lymphocyte antibodies associated with hypocomplementemia in chronic lymphocytic leukemia (CLL). Clin Exp Immunol. 1976;26:189-95
17. Massa MC, Connolly SM. An association between C1 esterase inhibitor deficiency and lupus erythematosus: report of two cases and review of the literature. J Am Acad Dermatol. 1982;7:255-64.
18. Pasquali JL, Christmann D, Modert F, Belval PC, Storck D, Hauptmann G. First case of acquired functional C1(-) INH deficiency: association with angioedema during Churg and Strauss vasculitis. Int Arch Allergy Appl Immunol. 1984;74:284-5.
19. Pascual M, Widmann JJ, Schifferli JA. Recurrent febrile panniculitis and hepatitis in two patients with acquired complement deficiency and paraproteinemia. Am J Med. 1987;83:959-62.
20. Jones RR, Baughan AS, Cream JJ, Levantine A, Whicher JT. Complement abnormalities in diffuse plane xanthomatosis with paraproteinemia. Br J Dermatol. 1979;101:711-6.
21. Cicardi M, Frangi D, Bergamaschini L, Gardinali M, Sacchi G, Agostoni A. Acquired C1 inhibitor deficiency with angioedema symptoms in a patient infected with Echinococcus granulosus. Complement. 1985;2:133-9.
22. Nilsen A, Matre R. Acquired angioedema and hypocomplementemia in a patient with myelofibrosis. Effect of danazol treatment. Acta Med Scand 1980;207:123-5.
23. Farkas H, Gyeney L, Majthenyi P, Fust G, Varga L. Angioedema due to acquired C1-esterase inhibitor deficiency in a patient with Helicobacter pylori infection. Z Gastroenterol. 1999;37:513-8
24. Jaffe CJ, Atkinson JP, Gelfand JA, Frank MM. Hereditary angioedema: the use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery J Allergy Clin Immunol. 1975;55:386-93
25. Frank MM, Sergent JS, Kane MA, Ailing DW. Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study. N Engl J Med. 1972;286:808-12.
26. Sheffer AL, Austen KF, Rosen FS. Tranexamic acid therapy in hereditary angioneurotic edema. N Engl J Med. 1972;287:452-4.
27. Donaldson VH, Bernstein DI, Wagner CJ, Mitchell BH, Scinto J, Bernstein IL. Angioneurotic edema with acquired C1-inhibitor deficiency and autoantibody to C1-inhibitor: response to plasmapheresis and cytotoxic therapy. J Lab Clin Med. 1992;119:397-406.
28. Bauernschmitt R, Bohrer H, Hagl S. Rescue therapy with C1-esterase inhibitor concentrate after emergency coronary artery surgery for failed PTCA. Intens Care Med. 1998;24:635-8.
29. Colman RW. Hereditary angioedema and heparin therapy [Letter]. Ann Intern Med. 1976;85:399-400.
30. Heda GD, Mardente S, Weiner L, Schmaier AH. Interferon gamma induces in vitro and in vivo expression of C1 inhibitor Blood. 1990;75:2401-7.
31. Bork K, Witzke G. Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibtor deficiency. J Allergy Clin Immunol. 1989;83:677-82.
32. Cugno M, Cicardi M, Agostoni A. Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid. J Allergy Clin Immunol. 1994;93:870-6.